Stephen L. Mayo, Ph.D.

Stephen L. Mayo, Ph.D.

DirectoratSarepta Therapeutics· In proxies 2023–2025

Stephen L. Mayo, Ph.D. sits on 2 public boards.

Boards1

  • Sarepta TherapeuticsDirector · 4 yr on the boardIndependentAudit, Research and Development—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Sarepta TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -85%
  2. Allogene TherapeuticsPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?